REQUEST A DEMO
Total
USD $0.00
Search more companies

The Arab Drug Company S.A.E (Egypt)

Main Activities: Medicinal and Botanical Manufacturing
Full name: The Arab Drug Company S.A.E Profile Updated: March 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Arab Drug Company S.A.E, located in Cairo, is one of the leading Egyptian pharmaceutical companies. It was incorporated in 1963. ADCO is known as the House of Aerosols and produces over 130 pharmaceutical products across 40 groups of drugs. The company has been awarded ISO 9001 and ISO 14001 certifications. ADCO operates modern production facilities that adhere to strict GMP regulations and has plans for facility upgrade and expansion.

Headquarters
5 Al-Masani St, Al Amireya, P.O Box 1343
Cairo; Greater Cairo; Postal Code: 1343

Contact Details: Purchase the The Arab Drug Company S.A.E report to view the information.

Website: http://www.adcopharma-eg.com

Basic Information
Total Employees:
Purchase the The Arab Drug Company S.A.E report to view the information.
Outstanding Shares:
Purchase the The Arab Drug Company S.A.E report to view the information.
Financial Auditors:
Purchase the The Arab Drug Company S.A.E report to view the information.
Incorporation Date:
1963
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
29.7%
Company Performance
Financial values in the chart are available after The Arab Drug Company S.A.E report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EGP. Absolute financial data is included in the purchased report.
Net sales revenue
25.22%
Total operating revenue
24.24%
Operating profit (EBIT)
1.63%
EBITDA
0.01%
Net Profit (Loss) for the Period
-1%
Total assets
23.97%
Total equity
24.44%
Operating Profit Margin (ROS)
-4.37%
Net Profit Margin
-3.79%
Return on Equity (ROE)
-1.71%
Debt to Equity Ratio
14.52%
Quick Ratio
0.69%
Cash Ratio
0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?